Antigen-Specific B-Cell Response to 13-Valent Pneumococcal Conjugate Vaccine in Asplenic Individuals With  -Thalassemia Previously Immunized With 23-Valent Pneumococcal Polysaccharide Vaccine

Ioanna Papadatou, Christina Piperi, Krystallenia Alexandraki, Antonis Kattamis, M. Theodoridou, Vana Spoulou

Clinical Infectious Diseases · 2014 · 30 citations · 11 references

DOIFull text

Open access

Concepts

Abstract

Current guidelines recommend a combined schedule of a 13-valent pneumococcal conjugate vaccine (PCV13) and PPSV23 (23-valent polysaccharide vaccine) for asplenic individuals. We show that PCV13 induces a T-dependent immune response in asplenic individuals with β-thalassemia, but previous PPSV23s affect the memory B-cell response in a dose- and time-dependent manner. Clinical Trials Registration. NCT01846923.

References

11